Anacor Pharmaceuticals, Inc. (ANAC) has 69 open-market insider trades by 22 insiders since 2010. The most active filer is Geoffrey M. Parker, President & VP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Anders D. Hove | Dir | — | 12 | $188.6M | 2016-06-24 |
| Mark Leschly | Dir | — | 2 | $12.3M | 2016-06-24 |
| Management Ventures Iv Llc Rho | 10% | — | 1 | $12.0M | 2010-11-30 |
| Lucy Shapiro | Dir | — | 2 | $11.2M | 2016-06-24 |
| Vincent P. Ippolito | CCOVP | — | 6 | $5.1M | 2016-06-24 |
| Glaxosmithkline PLC | 10% | — | 1 | $5.0M | 2010-11-24 |
| Carmen R. Rodriguez | Snr VP Reg Afrs & Qual. Assur. | — | 1 | $3.9M | 2015-05-14 |
| Management Iv Llc Vef | 10% | — | 1 | $3.0M | 2012-07-02 |
| Kirk R. Maples | SVPProgram Management | — | 12 | $2.9M | 2015-06-01 |
| Paul L. Berns | CEOPres | — | 3 | $2.8M | 2016-06-24 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Graeme Bell | CFO & VP | Sell | $149K | 2016-06-01 |
| Keith R. Leonard | Director | Sell | $897K | 2016-05-23 |
| Anders D. Hove | Director | Sell | $70.5M | 2016-05-16 |
| Ryan T. Sullivan | CLO & VP | Sell | $415K | 2016-04-29 |
| Anders D. Hove | Director | Sell | $271K | 2016-04-08 |
| Anders D. Hove | Director | Sell | $16.0M | 2016-04-07 |
Companies that share insiders with ANAC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Anders D. Hove | Director | Sell | $16.3M | 2016-04-07 |
| Paul L. Berns | CEO & President | Sell | $2.3M | 2016-03-22 |
| Vincent P. Ippolito | CCO & VP | Sell | $931K | 2016-03-02 |
| Vincent P. Ippolito | CCO & VP | Sell | $575K | 2016-03-02 |
| Vincent P. Ippolito | CCO & VP | Sell | $1.9M | 2016-01-19 |
| Vincent P. Ippolito | CCO & VP | Sell | $1.9M | 2016-01-19 |
| Lee Zane | VP | Sell | $263K | 2016-01-15 |
| Paul L. Berns | CEO & President | Sell | $560K | 2016-01-04 |
| Vincent P. Ippolito | CCO & VP | Sell | $62K | 2016-01-04 |